Javascript must be enabled to continue!
Lipid-Based Nanocarriers and Applications in Medicine
View through CrossRef
Lipid nanocarriers have recently arisen with a wide range of uses and
research areas, with the advantages they offer in virtue of their unique properties. They
are easily synthesized, scaled up, biodegradable, proper to transport many bioactive
components, have a high loading capacity, and are convenient for various routes of
administration (parenteral, oral, dermal, ocular, etc.). These carriers overcome the
problems of bioactive substances such as low solubility, plasma half-life and
bioavailability, and side effects, as well as providing controlled release, local delivery,
and targeting. Lipid-based nanoparticular systems can be categorized into two basic
classes, vesicular and non-vesicular. While liposomes are the most widely used
vesicular structures, solid lipid nanoparticles and nano-structured lipid carriers are non-vesicular nanocarriers. These nanocarriers have many medical uses, such as cancer
therapy, gene therapy, photodynamic therapy, treatment of infectious diseases and
neurodegenerative diseases, vaccines, imaging, etc. It is essential that the synthesis
method of lipid-based nanocarriers and the components from which they are composed
are selected in accordance with the medical application area and characterization
studies are carried out. In this article, liposomes, solid lipid nanoparticles and nano-structured lipid carriers will be discussed as lipid-based nanocarriers, synthesis and
characterization methods will be emphasized and examples from medical applications
will be given.
Title: Lipid-Based Nanocarriers and Applications in Medicine
Description:
Lipid nanocarriers have recently arisen with a wide range of uses and
research areas, with the advantages they offer in virtue of their unique properties.
They
are easily synthesized, scaled up, biodegradable, proper to transport many bioactive
components, have a high loading capacity, and are convenient for various routes of
administration (parenteral, oral, dermal, ocular, etc.
).
These carriers overcome the
problems of bioactive substances such as low solubility, plasma half-life and
bioavailability, and side effects, as well as providing controlled release, local delivery,
and targeting.
Lipid-based nanoparticular systems can be categorized into two basic
classes, vesicular and non-vesicular.
While liposomes are the most widely used
vesicular structures, solid lipid nanoparticles and nano-structured lipid carriers are non-vesicular nanocarriers.
These nanocarriers have many medical uses, such as cancer
therapy, gene therapy, photodynamic therapy, treatment of infectious diseases and
neurodegenerative diseases, vaccines, imaging, etc.
It is essential that the synthesis
method of lipid-based nanocarriers and the components from which they are composed
are selected in accordance with the medical application area and characterization
studies are carried out.
In this article, liposomes, solid lipid nanoparticles and nano-structured lipid carriers will be discussed as lipid-based nanocarriers, synthesis and
characterization methods will be emphasized and examples from medical applications
will be given.
Related Results
Lipid-Based Nanocarriers: Development and Assessment for Treatment of Hypertension
Lipid-Based Nanocarriers: Development and Assessment for Treatment of Hypertension
Introduction: Worldwide, hypertension continues to be a leading cause of cardiovascular disease-related illness and death. Problems with systemic side effects, inadequate bioavaila...
Lipidic nanocarriers of plant bioactives as potential drug delivery and targeting systems for effective cancer treatment
Lipidic nanocarriers of plant bioactives as potential drug delivery and targeting systems for effective cancer treatment
All over the world, cancer is the leading cause of death. On the other hand, the efficacy of existing mainstream cancer treatments is unsatisfactory for a range of tumors. To begin...
Lipid-Based Nanocarriers: Bridging Diagnosis and Cancer Therapy
Lipid-Based Nanocarriers: Bridging Diagnosis and Cancer Therapy
Theranostics is a growing field that matches diagnostics and therapeutics. In this approach, drugs and techniques are uniquely coupled to diagnose and treat medical conditions syne...
Nanocarriers in Drug Delivery Systems: An Overview
Nanocarriers in Drug Delivery Systems: An Overview
Nanocarriers have emerged as a transformative technology in drug delivery systems (DDS), offering significant advancements over traditional methods. This review delves into the var...
P197 Similarity and difference in in-stent neoatherosclerosis assessment between near-infrared spectroscopy and optical coherence tomography
P197 Similarity and difference in in-stent neoatherosclerosis assessment between near-infrared spectroscopy and optical coherence tomography
Abstract
Backgrounds
Near-infrared spectroscopy (NIRS) has been implicated to assess the composition of the atherosclerotic plaq...
Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence
Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence
There has been an increasing demand for the development of nanocarriers targeting multiple diseases with a broad range of properties. Due to their tiny size, giant surface area and...
Stimuli-Responsive Nanocarriers for Site-Specific Drug Delivery System
Stimuli-Responsive Nanocarriers for Site-Specific Drug Delivery System
Stimuli-responsive nanocarriers have emerged as a promising tool for site-specific drug delivery, offering improved therapeutic efficacy and reduced side effects. These nanocarrier...
Compartmentalization of Jojoba Seed Lipid Metabolites
Compartmentalization of Jojoba Seed Lipid Metabolites
Seeds from the desert shrub Simmondsia chinensis (jojoba) are one of the only known natural plant sources to store a majority of its oil in the form of liquid wax esters (WE) inste...

